Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin i

American Heart Journal

Volumn 160, Issue 5, 2010, Pages 835-841

  Venge, Per ^a   Öhberg, Claes ^a   Flodin, Mats ^b   Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; EMERGENCY WARD; FEMALE; HEART INJURY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SWEDEN; TIME FACTORS; TROPONIN I;

EID: 78649344960     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.036     Document Type: Article

References (24)

1. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
2. Apple F.S., Jesse R.L., and Newby L.K. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes Clin Chem 53 2007 547 551
3. Panteghini M., Pagani F., and Yeo K.T. Evaluation of imprecision for cardiac troponin assays at low-range concentrations Clin Chem 50 2004 327 332
4. Eggers K.M., Jaffe A.S., and Lind L. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making Clin Chem 55 2009 85 92
5. Venge P., James S., and Jansson L. Clinical performance of two highly sensitive cardiac troponin I assays Clin Chem 55 2009 109 116
6. Eggers K.M., Lagerqvist B., and Oldgren J. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome Am Heart J 156 2008 588 594
7. Venge P., Johnston N., and Lagerqvist B. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy Clin Chem 49 2003 880 886
8. Venge P., Lagerqvist B., and Diderholm E. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy) Am J Cardiol 89 2002 1035 1041
9. Kavsak P.A., Macrae A.R., and Yerna M.J. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury Clin Chem 55 2009 573 577
10. Kavsak P.A., Newman A.M., and Lustig V. Long-term health outcomes associated with detectable troponin I concentrations Clin Chem 53 2007 220 227
11. Zethelius B., Berglund L., and Sundstrom J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
12. Zethelius B., Johnston N., and Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study Circulation 113 2006 1071 1078
13. Venge P., Johnston N., and Lindahl B. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia J Am Coll Cardiol 54 2009 1165 1172
14. Eggers K.M., Lagerqvist B., and Venge P. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality Circulation 116 2007 1907 1914
15. James S., Flodin M., and Johnston N. The antibody configurations of cardiac troponin I assays may determine their clinical performance Clin Chem 52 2006 832 837
16. Apple F.S., Murakami M.M., and Christenson R.H. Analytical performance of the i-STAT cardiac troponin I assay Clin Chim Acta 345 2004 123 127
17. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease: the present and the future J Am Coll Cardiol 48 2006 1 11
18. Apple F.S., Wu A.H., and Jaffe A.S. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure Clin Biochem 53 2007 547 551
19. Apple F.S., Parvin C.A., and Buechler K.F. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction Clin Chem 51 2005 2198 2200
20. James S.K., Lindahl B., and Armstrong P. A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes Int J Cardiol 93 2004 113 120
21. Singh J., Akbar M.S., and Adabag S. Discordance of cardiac troponin I assays on the point-of-care i-STAT and Architect assays from Abbott diagnostics Clin Chim Acta 403 2009 259 260
22. Kupchak P., Wu A.H., and Ghani F. Influence of imprecision on ROC curve analysis for cardiac markers Clin Chem 52 2006 752 753
23. Keller T., Zeller T., and Peetz D. Sensitive troponin I assay in early diagnosis of acute myocardial infarction N Engl J Med 361 2009 868 877
24. Reichlin T., Hochholzer W., and Bassetti S. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867